Projects
-
Role of the endocannabinoidome-gut microbiome axis in anxiety and pain (Guida et al 2018., Guida et al., 2020).
-
Role of endocannabinoidome signaling in neuroprotection, addiction, pain, inflammation and skeletal muscle development (Cristino et al., 2020; Piscitelli et al., 2020; Petrosino et al., 2019; Ferrara et al., 2019; Petrie et al., 2019; Ligresti et al., 2019; Donvito et al., 2019; Iannotti et al., 2018).
-
Pharmacology and potential therapeutic use in inflammatory, metabolic and neuropsychiatric disorders of non-euphoric plant cannabinoids: emphasis on cannabidiol, cannabidivarin, tetrahydrocannabidivarin, cannabigerol and their acid precursors (Iannotti et al., 2019; Stark et al., 2019; D’Aniello et al., 2019; Zamberletti et al., 2019; Alalawi et al., 2019; Pagano et al., 2019; Fellous et al., 2020; Gamelin et al., 2020).
-
Study of the potential deleterious effects of excessive perinatal CB1 receptor activity on brain development (Cinquina et al., 2020).
-
Orexin-endocannabinoid interactions in food-intake and obesity and its complications (Imperatore et al., 2018; Tunisi et al., 2019).